In order to put the results of SENIORS in the context of previous beta-blocker trials, which recruited younger patients and excluded patients with higher ejection fractions, we identified the subgroup of patients most similar to the previous major outcome trials.
Oxford University Press is a department of the University of Oxford.
Patients with HF can be divided into two different groups based on EF: As this is an investigator-initiated trial, the authors designed and conducted the study. Coats has received honoraria from Menarini. The beneficial effects appear after 6 months of treatment and the risk reduction continues to increase with longer treatment.
The primary outcome was the composite of all cause mortality or cardiovascular hospital admission time to first event. The need for additional data has been emphasized.
HF with preserved or reduced EF [ 13 ]. N Engl J Med. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta adrenergic blockade. Analysis was by intention to treat. In all four interim unblinded analyses, 19 no reason was found for safety concerns.
If tolerated, it will be increased to 2. BIsoprolol in moderate heart failure: Babalis's department has received a grant from Menarini.
This trial is a single-center study that aims to evaluate the impact of nebivolol on LV diastolic function.
Abbreviations and Acronyms
In addition, as reported above, the risk of attrition bias due to missing data has been adequately prevented and will be treated. Randomization following initial echocardiographic testing can be performed immediately after enrollment for patients who fulfill all the eligibility requirements. Expert consensus document on beta-adrenergic receptor blockers.
The effect of nebivolol was investigated in these 2 groups, and it was compared to explore the interaction of EF with outcome. Key Words heart failure. Differences between patients with a preserved and a depressed left ventricular function: Heart failure with preserved left ventricular systolic function.
Heart failure is characterized by changes in many neurohormonal mechanisms, but notably activation of the sympathetic and renin—angiotensin—aldosterone systems. Patients were allocated a treatment number which corresponded to the appropriate study treatment packs.